Avandia Critics Try Drug In Court Of Public Opinion, Turn Up Heat On FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency whistleblower Graham and advisory committee panelists air grievances about GSK "TIDE" letter in the mainstream press.